Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.67745 | 61 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.48981 | 58 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.51648 | 58 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.45296 | 58 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.46708 | 58 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.60448 | 58 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.56541 | 58 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.46942 | 57 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.50556 | 58 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.50595 | 59 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.51082 | 58 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.53051 | 59 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.51752 | 58 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.51532 | 59 |